Our Mission
With a staff of ~70 employees, AiCuris’ head office and research laboratories are located at the Pharma- and Chemistry Park in Wuppertal, Germany, where the company occupies 5.500 square meters, including 3.500 square meters of purpose-built biology and pharmacokinetics facilities. Committed to making the difference, we have more than 15 years of experience in advancing novel approaches. The Company’s first product, Letermovir (Prevymis®), a first-in-class therapy for human cytomegalovirus (HCMV) infections, was successfully out-licensed to Merck & Co., is marketed since 2017 with growing revenues, and has won several prizes for providing a paradigm shift in transplant medicine.